MRM — MEDIROM Healthcare Technologies Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesAdventurousMicro Cap
- $29.69m
- $32.27m
- ¥3bn
Annual income statement for MEDIROM Healthcare Technologies, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 3,433 | 3,908 | 3,342 |
| Cost of Revenue | |||
| Gross Profit | 957 | 951 | 429 |
| Selling / General / Administrative Expenses | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 3,360 | 3,874 | 3,976 |
| Operating Profit | 73.3 | 34.4 | -635 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 91.9 | 32.7 | -627 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 66.7 | 16.8 | -539 |
| Net Income Before Extraordinary Items | |||
| Net Income | 66.7 | 16.8 | -539 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 66.3 | 17.3 | -539 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 19.9 | 8.33 | -135 |